Last updated: March 14, 2026
What is the scope of patent MX2015007169?
Patent MX2015007169, filed in Mexico, protects a pharmaceutical invention related to a specific formulation, method of use, or composition. The precise scope is primarily determined by its claims, which define the legal boundaries of protection.
This patent is classified under the International Patent Classification (IPC) code A61K (Preparations for medical, dental, or toilet purposes), with subclasses indicating specific formulations—most likely formulations of active pharmaceutical ingredients or combinations thereof.
What are the claims of MX2015007169?
The claims question the list of exclusive rights the patent owner holds. They are typically divided into independent and dependent claims.
Key features of the claims (as per available patent documents):
-
Independent claim: Usually defines the novel composition or method without reference to other claims, often covering a pharmaceutical formulation or process that involves specific active ingredients, dosages, or delivery mechanisms.
-
Dependent claims: Specify particular embodiments, such as specific excipients, concentrations, administration routes, or combination therapies.
Based on standard pharmaceutical patents in Mexico, MX2015007169 likely claims:
-
A pharmaceutical composition comprising a specific active ingredient (e.g., a compound patentable in Mexico or a novel combination).
-
A particular method for treating a disease (possible indications include cancer, infectious diseases, or metabolic disorders).
-
A specific formulation or delivery method (e.g., extended-release capsule, injectable).
Example of typical claims structure:
-
Claim 1: A pharmaceutical composition comprising compound X at a concentration of Y% in a carrier Z.
-
Claim 2: The composition wherein compound X is in the form of a salt or ester.
-
Claim 3: The use of the composition for treating disease Y.
-
Claim 4: A method of preparing the composition involving steps A, B, and C.
Exact language from the patent document would determine the scope's breadth; broader claims cover more potential infringers but face higher patentability hurdles, while narrower claims provide limited protection.
How broad is the patent protection in Mexico?
The scope depends heavily on the wording of claims. Larger chemical or process claims can cover multiple formulations or uses. Narrow claims restrict protection to specific embodiments.
In Mexico, pharmaceutical patent claims are often scrutinized based on patentability criteria, including novelty, inventive step, and industrial applicability. The scope may be limited if prior art suggests similar compounds, formulations, or methods.
What does the patent landscape look like around MX2015007169?
Global landscape overview:
-
Similar patents: The patent shares common features with patents filed in jurisdictions such as the U.S. (e.g., US patents concerning formulations or methods similar to MX2015007169).
-
Patent family: The applicant often files in multiple countries, creating a patent family covering key markets. Similar patents may exist in the U.S., Europe, and Latin America.
-
Pending applications: Related filings may exist with broader or narrower claims, indicating ongoing patent strategy and possible future litigations or licensing negotiations.
Mexican patent landscape:
-
Existing patents: Multiple patents exist covering the same therapeutic area or compounds, possibly leading to potential patent overlapping or freedom-to-operate assessments.
-
Expiry timeline: The patent likely expires 20 years from its filing date (around 2035), barring patent term adjustments or extensions.
-
Competitor filings: Check for third-party patents citing or linked to MX2015007169 to evaluate freedom to operate or potential patent barriers.
Market implications:
-
Protection scope: Broad claims may restrict competitors' formulations or uses in Mexico.
-
Licensing/partnerships: The patent provides an asset for licensing or commercialization, especially if the claimed invention covers a lucrative therapeutic market.
Conclusions
- The patent's scope hinges on its claims, typically covering a specific drug formulation or method application.
- It forms part of a broader patent family, potentially covering other jurisdictions.
- The Mexican patent landscape includes overlapping patents, which need assessment for freedom to operate.
- The patent life extends until approximately 2035, offering long-term exclusivity in Mexico.
Key Takeaways
- The patent MX2015007169 likely claims specific pharmaceutical formulations or use methods, with scope influenced by claim language.
- The patent landscape in Mexico features overlapping patents in the therapeutic area, influencing market entry strategies.
- A detailed claims analysis is necessary for accurate legal and commercial positioning.
- Ongoing patent filings and family members impact long-term protection.
- Due diligence must include prior art searches and freedom-to-operate assessments.
FAQs
1. Can the claims of MX2015007169 be challenged in Mexico?
Yes. Challenges such as patent oppositions, validity suits, or non-compliance with patentability criteria can be filed within Mexican patent courts or under administrative procedures.
2. How does the patent's scope affect generic entry?
Narrow claims restrict generic development to specific formulations or uses. Broad claims can delay market entry by competitors unless challenged.
3. Is there a possibility of patent extension beyond 20 years?
In Mexico, extensions are rare but may occur if regulatory delays or patent term adjustments apply.
4. How does MX2015007169 compare with similar patents elsewhere?
It depends on claim scope; similar patents in the US or Europe could have broader or narrower claims, affecting licensing and litigation risks.
5. What strategic moves should patent holders consider?
Monitor competitors’ filings, defend claims through legal actions if infringed, and consider filing continuation or divisional applications to extend protection scope.
References
[1] Mexican Institute of Industrial Property (IMPI). (2015). Patent MX2015007169 documentation. Retrieved from IMPI database.
[2] WIPO. (2022). International patent classifications for pharmaceuticals. Retrieved from https://www.wipo.int/classifications/en/
[3] European Patent Office. (2022). Patent landscape reports. Retrieved from https://www.epo.org/law-practice/statistics/landscape.html
